EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Interleukin-22: the hub bridging gut homeostasis and metabolism

Shupei Wang, Jingyi Gong, Jiaxi Wang, Wei-Le Wang, Li-Hao Huang

Trends in Immunology · 2026

DOI: 10.1016/j.it.2025.10.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026. Verfasst von Shupei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospit…. Hauptthemen laut MEDLINE: Interleukins, Inflammatory Bowel Diseases, Intestinal Mucosa. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Science and Technology Council, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-22, produced by various cell types including T helper (Th) 17 cells and group 3 innate lymphoid cells (ILC3s), plays a pivotal role in gut homeostasis by acting on non-hematopoietic cells. It promotes epithelial barrier integrity, tissue repair, and antimicrobial defense. Beyond its established function in mucosal immunity, emerging evidence reveals IL-22's involvement in regulating intestinal metabolism and protecting against systemic metabolic dysregulation. This review highlights recent advances in preclinical mouse models and human clinical data in IL-22 biology, focusing on its dual role in immune defense and metabolic control. Given the strong link between inflammatory bowel disease (IBD) and metabolic disorders, we further discuss IL-22's therapeutic potential in mitigating both intestinal inflammation and related metabolic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterleukinsInflammatory Bowel DiseasesIntestinal MucosaInterleukin-22HumansAnimalsHomeostasisImmunity, InnateMiceImmunity, MucosalGastrointestinal Microbiome

Stichwörter der Autor:innen

epithelial barrierinflammatory bowel diseaseintestinal metabolismmetabolic disordersmucosal immunity

Substanzen

Interleukin-22Interleukins

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200438, China.
  • The Human Phenome Institute, Center for Integrative Spatial-Omics Research, Zhangjiang-Fudan International Innovation Center, Fudan University, Shanghai 200438, China. Electronic address: jiaxiwang@fudan.edu.cn.
  • Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan. Electronic address: Wangweile@as.edu.tw.
  • Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200438, China. Electronic address: Liha…

Förderung

  • National Science and Technology Council
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Wang, S., Gong, J., Wang, J., Wang, W. L., & Huang, L. H. (2026). Interleukin-22: the hub bridging gut homeostasis and metabolism. Trends in Immunology. https://doi.org/10.1016/j.it.2025.10.009

Vancouver

Wang S, Gong J, Wang J, Wang WL, Huang LH. Interleukin-22: the hub bridging gut homeostasis and metabolism. Trends in Immunology. 2026. doi:10.1016/j.it.2025.10.009

BibTeX
@article{Wang2026,
  author = {Wang, Shupei and Gong, Jingyi and Wang, Jiaxi and Wang, Wei-Le and Huang, Li-Hao},
  title = {Interleukin-22: the hub bridging gut homeostasis and metabolism},
  journal = {Trends in Immunology},
  year = {2026},
  doi = {10.1016/j.it.2025.10.009}
}
Kostenlos starten →